1. Panoramica del prodotto
Docetaxel 99% is a highly purified semi-synthetic taxane API widely used in anti-tumor formulations. Known for its strong microtubule-stabilizing activity, Docetaxel is a key ingredient in oncology products targeting breast cancer, NSCLC, prostate cancer, gastric cancer, head & neck cancers, and more.
At Zhonghong Biotech, we supply pharmaceutical-grade Docetaxel 99% manufactured under GMP-aligned production standards, with complete documentation including COA, MSDS, chromatographic profiles, method validation, and regulatory support files.
Our raw material is sourced from high-quality 10-deacetylbaccatin III (10-DAB), ensuring stable production, reliable batch consistency, and competitive factory-direct pricing for industrial buyers.
2. Fonte botanica e origine
Docetaxel is a semi-synthetic derivative of paclitaxel precursors isolated from:
-
Taxus chinensis,
-
Taxus yunnanensis,
-
Taxus brevifolia,
-
e altro Tasso specie.
Noi usiamo 10-DAB (10-Deacetylbaccatin III) extracted from cultivated Taxus needles and branches. The semi-synthetic route ensures sustainability (no bark harvesting) and stable large-scale supply.
3. Key Technical Parameters
| Parametro | Descrizione |
|---|---|
| Nome del prodotto | Docetaxel |
| Purezza | ≥ 99% (HPLC) |
| Numero CAS | 114977-28-5 |
| Formula molecolare | C43H53NO14 |
| Peso molecolare | 807.9 |
| Aspetto | Polvere cristallina da bianca a biancastra |
| Grado | Farmaceutico / API |
| Metodo di produzione | Semi-synthetic from 10-DAB |
| Solubilità | Insoluble in water; soluble in ethanol, methanol, DMSO |
| Standard | In-house + reference to USP/EP |
4. Benefits & Mechanism of Action
1) Stabilizes Microtubules
Docetaxel enhances tubulin polymerization and prevents depolymerization, arresting cancer cells in the G2/M phase.
Supported by PubMed studies.
2) Broad Antitumor Activity
Indicated in multiple solid tumors, including:
-
Breast cancer
-
Prostate cancer
-
NSCLC
-
Gastric cancer
-
Head & neck cancer
3) Stronger Activity than Paclitaxel
Docetaxel shows:
-
Higher cellular uptake
-
Higher binding affinity to tubulin
-
Prolonged microtubule stabilization
4) Synergy
Used in combination with:
-
Carboplatin
-
Cisplatin
-
Doxorubicin
-
Capecitabine
5. Health & Clinical Relevance
Docetaxel is included in global oncology guidelines:
-
NCCN Guidelines
-
FDA-approved indications
-
EMA-approved oncology products
Mechanisms include:
-
Indurre l'apoptosi
-
Inhibiting angiogenesis
-
Blocking cancer metastasis
6. Guida all'applicazione
Docetaxel 99% is ideal for:
-
API manufacturing
-
Injection formulations
-
Liposome preparations
-
Nanoparticle formulations
-
Lyophilized powder production
7. Recommended Usage (for industrial formulating)
| Applicazione | Typical Use Level |
|---|---|
| Injection (concentrate) | 10–40 mg/mL (in solvent systems) |
| Polvere liofilizzata | Formulazioni personalizzate |
| Nano-carriers | As per formulation design |
| R&D / Lab Use | Based on protocol requirements |
Note: Not for direct human use; suitable for formulation manufacturing only.
8. Migliori pratiche di formulazione
-
Use ethanol + polysorbate-80 system for solubilization.
-
Protect from light and oxidation during processing.
-
Maintain ≤ 25°C environment during formulation.
-
Use nitrogen protection if needed to avoid degradation.
-
Validate HPLC method for every batch.
9. Sicurezza e precauzioni
-
Documented cytotoxic compound—handle with PPE.
-
Use fume hood during production.
-
Store in sealed, light-resistant containers.
-
Follow FDA cytotoxic manufacturing guidelines.
10. Product Specifications (Docetaxel 99%)
| Articolo | Specificazione | Metodo |
|---|---|---|
| Aspetto | White/off-white powder | Visivo |
| Identificazione | Positivo | IR / HPLC |
| Saggio | ≥ 99% | HPLC |
| Related substances | ≤ 1,0% | HPLC |
| Solventi residui | Conforme | GC |
| Perdita all'essiccazione | ≤ 1,0% | USP |
| Residue on ignition | ≤ 0,2% | USP |
| Specific rotation | +28° to +34° | USP |
11. COA – Pesticides, Heavy Metals, Microbiological Testing
A) Pesticide Residues (USP / EP / ChP)
| Pesticide Test | Limite | Metodo |
|---|---|---|
| Pesticidi organoclorurati | ≤ 0,1 mg/kg | GC-MS |
| pesticidi organofosforici | ≤ 0,1 mg/kg | GC-MS |
| Pesticidi piretroidi | ≤ 0,1 mg/kg | GC-MS |
| Pesticidi carbammati | ≤ 0,1 mg/kg | LC-MS/MS |
| Residui totali di pesticidi | Conforme | GC-MS / LC-MS/MS |
B) Heavy Metals (ICP-MS / AAS)
| Metallo pesante | Limite | Metodo |
|---|---|---|
| Piombo (Pb) | ≤ 2 ppm | ICP-MS |
| Arsenico (As) | ≤ 1 ppm | ICP-MS |
| Cadmio (Cd) | ≤ 1 ppm | ICP-MS |
| Mercurio (Hg) | ≤ 0,1 ppm | ICP-MS |
| Metalli pesanti totali | ≤ 10 ppm | USP <233> |
C) Microbial Testing (USP <61>/<62>)
| Articolo microbico | Limite | Metodo |
|---|---|---|
| Conteggio totale delle piastre (TPC) | ≤ 1000 ufc/g | USP <61> |
| Lievito e muffa | ≤ 100 ufc/g | USP <61> |
| Escherichia coli | Negativo | USP <62> |
| Salmonella | Negativo | USP <62> |
| Stafilococco aureo | Negativo | USP <62> |
| Pseudomonas aeruginosa | Negativo | USP <62> |
12. Production Process (Public Version)
Semi-synthetic Production Route from 10-DAB
-
Raw Material Extraction
Extraction of 10-deacetylbaccatin III (10-DAB) from Taxus leaves. -
Side-chain Synthesis
Preparation of the phenylisoserine side chain. -
Esterification & Coupling
Coupling of 10-DAB with the activated side chain. -
Protection / Deprotection Steps
Removing protecting groups to form the Docetaxel backbone. -
Purificazione
Multi-step purification through crystallization and chromatography. -
Essiccazione e macinazione
Controlled drying under low temperature. -
Confezione
Final API packed in sterile, sealed containers.
13. Production Flowchart
10-DAB Extraction → Side Chain Preparation → Esterification → Coupling → Deprotection → Purification → Drying → Milling → Packaging → QC Release
14. Storage & Shelf Life
-
Conservare presso 2–8°C, protected from light.
-
Keep container tightly sealed.
-
Shelf Life: 24 months under recommended conditions.
15. Packaging Options
-
1 g / 5 g / 10 g / 100 g / 1 kg
-
Triple-layer package:
-
inner sterile bottle
-
aluminum foil bag
-
outer drum
-
Custom packaging is available.
16. Sample Policy
-
Free 1–5 g samples for qualified buyers.
-
Courier cost can be paid by recipient or deducted from order.
17. Shipping & MOQ
-
MOQ: 1 g (for R&D)
-
MOQ: 100 g (for commercial production)
-
Global shipping via DHL / FedEx / air cargo.
-
GMP-aligned bulk manufacturing.
18. Application Industries
-
Pharmaceutical manufacturing
-
Oncology API suppliers
-
Research institutes
-
Clinical formulation companies
-
CDMO / CRO partners
19. Application Scenarios
-
Injectable chemotherapy formulation
-
Lyophilized powder development
-
Nano-drug delivery systems
-
Oncology R&D projects
-
Toxicology studies
20. How to Use (for Manufacturing)
-
Dissolve in ethanol.
-
Add polysorbate-80.
-
Filter through 0.22 µm membrane.
-
Dilute to final concentration.
-
Aseptic filling.
21. Why Choose Shaanxi Zhonghong?
Competenza
-
15+ years experience in taxane API production
-
Professional R&D team
-
GMP-oriented system and validated methods
Autorità
-
Third-party lab testing (Eurofins, SGS optional)
-
Full documentation: COA, MSDS, NMR, HPLC
Fiducia
-
Materie prime tracciabili
-
Batch consistency
-
Real factory photos and videos available
Esperienza
-
Exported to 40+ countries
-
Long-term cooperation with pharmaceutical companies
22. Frequently Asked Questions (FAQ)
1. What is the purity of your Docetaxel?
≥ 99% (HPLC), pharmaceutical grade.
2. Can I get a sample?
Yes, 1–5 g samples available.
3. Do you provide regulatory documents?
Yes: COA, MSDS, HPLC, method validation.
4. What’s your MOQ?
1 g for R&D; 100 g for commercial use.
5. What’s your lead time?
1–3 days for sample; 7–15 days for bulk.
23. References (PubMed / FDA / NIH)
-
Taxanes in cancer therapy – Nature Reviews Cancer
-
Docetaxel pharmacology – Clinical Cancer Research
Manufacturer: Shaanxi Zhonghong Investment Technology Co., Ltd.
Sito web: aiherba.com • E-mail: sales@aiherba.com / info@aiherba.com / liaodaohai@gmail.com





